REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options / PDMR dealing

14 May 2021 10:11

RNS Number : 6827Y
Sopheon PLC
14 May 2021
 

For Immediate Release

 

 

 

 

SOPHEON PLC

("Sopheon" or "the Company")

 

Grant of Options / PDMR dealing

 

Sopheon announces that the Company has granted options over ordinary shares of 20 pence each in the share capital of the Company ("Options") to three executive directors.

 

Gregory Coticchia, the recently appointed CEO has been granted 80,000 Options at an exercise price of 845p, being the mid-market closing price on AIM on 13 May 2021, the last business day prior to the grant. Including this grant, the total number of Options held by him is 100,000.

 

Andrew Michuda, Executive Chairman and Arif Karimjee, CFO have been granted 165,000 and 43,350 Options respectively at an exercise price of 900p. Including this grant, the total number of Options held by each is 320,000 and 93,000 respectively.

 

The Options granted will vest over 3 years and are exercisable up to 10 years from the date of grant. Including the grant of these options, the Company will have outstanding options over approximately 9.5% of its issued share capital.

 

Notice of AGM

 

The Company also confirms it is posting its Notice of AGM ("Notice") to shareholders today, and will also publish the Notice on the Company's website. The AGM will be held on 10 June 2021.

 

For further information contact:

Andy Michuda, Executive ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes / Giles Rolls (corporate finance)

Alice Lane (ECM)

finnCap Ltd

+ 44 (0) 20 7220 0500

 

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade® solution provides unique, fully integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 250 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION EU NO. 596/2014, AS RETAINED AND APPLICABLE IN THE UK PURSUANT TO S3 OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR").

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Gregory Coticchia

2.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sopheon plc

b)

LEI

213800TA9E6UG2WWG646

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over ordinary shares of 20p

 

Identification code

GB00BSZM1369

b)

Nature of the transaction

 

Grant of Options

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price 845 pence per share

80,000

 

d)

Aggregated information:

· Aggregated volume

· Price

 

Grant of 80,000 options over ordinary shares of 20p pence at an exercise price of 845 pence

e)

Date of the transaction

14 May 2021

f)

Place of the transaction

Outside of trading venue

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

2.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Arif Karimjee

3.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

 

4.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sopheon plc

b)

LEI

213800TA9E6UG2WWG646

5.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over ordinary shares of 20p

 

Identification code

GB00BSZM1369

b)

Nature of the transaction

 

Grant of Options

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price 900 pence per share

43,350

 

d)

Aggregated information:

· Aggregated volume

· Price

 

Grant of 43,350 options over ordinary shares of 20p pence at an exercise price of 900 pence

e)

Date of the transaction

14 May 2021

f)

Place of the transaction

Outside of trading venue

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

5.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Michuda

6.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

 

7.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sopheon plc

b)

LEI

213800TA9E6UG2WWG646

8.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over ordinary shares of 20p

 

 

Identification code

GB00BSZM1369

b)

Nature of the transaction

 

Grant of Options

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise Price 900 pence per share

165,000

 

d)

Aggregated information:

· Aggregated volume

· Price

 

Grant of 165,000 options over ordinary shares of 20p pence at an exercise price of 900 pence

e)

Date of the transaction

14 May 2021

f)

Place of the transaction

Outside of trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKQBKCBKKAPD
Date   Source Headline
3rd Nov 202310:15 amRNSForm 8.5 (EPT/NON-RI)
3rd Nov 20238:54 amRNSForm 8.3 - Rivomore Limited - Sopheon plc
2nd Nov 20239:34 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20233:44 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 Apex Fundrock Limited Re: Sopheon PLC
1st Nov 20231:55 pmRNSForm 8.3 - Sopheon plc
1st Nov 202311:23 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 202310:51 amGNWForm 8.3 - [Sopheon plc - Opening Declaration - 31 03 2023] - (CGAML)
1st Nov 202310:35 amRNSForm 8.3 - Sopheon PLC
31st Oct 20231:00 pmRNSStatement re Possible Offer
24th Aug 20237:00 amRNSInterim Results
10th Jul 20237:00 amRNSAcquisition
15th Jun 20235:06 pmRNSIssue of Equity
8th Jun 20231:35 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Statement
13th Apr 20234:20 pmRNSIssue of Equity
31st Mar 20239:14 amRNSIssue of Equity
27th Mar 20234:23 pmRNSDirector Shareholdings
24th Mar 20237:00 amRNSDirector Share Purchases
23rd Mar 20237:00 amRNSFinal Results
22nd Feb 20234:59 pmRNSIssue of Equity
6th Feb 20237:00 amRNSDirectorate Change and Notice of Results
30th Jan 20237:00 amRNSTrading Update
20th Sep 202212:01 pmRNSSopheon launches Acclaim Line of SaaS Offerings
2nd Sep 202210:06 amRNSIssue of Equity
1st Sep 20227:00 amRNSNew Release of Award-winning Innovation Product
24th Aug 20227:00 amRNSInterim Results
16th Aug 20227:00 amRNSFive-year, $11.2m Enterprise Agreement
3rd Aug 202210:18 amRNSHolding(s) in Company
21st Jun 202212:20 pmRNSHolding(s) in Company
9th Jun 20222:30 pmRNSResult of AGM
9th Jun 20227:00 amRNSAGM Statement
6th Jun 20226:02 pmRNSIssue of Equity & TVR
23rd May 20227:00 amRNSDirector Dealing & Issue of Equity
18th May 20227:00 amRNSAcquisition
29th Apr 20225:12 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSNew Sopheon Software Release
1st Apr 202212:10 pmRNSDirector Shareholdings
24th Mar 20227:00 amRNSFinal Results
25th Jan 20227:00 amRNSTrading Update
17th Jan 20223:15 pmRNSIssue of Equity
20th Dec 20217:00 amRNSAcquisition and Trading Update
24th Sep 20211:52 pmRNSIssue of Equity
16th Sep 202110:00 amRNSHolding(s) in Company
13th Sep 20215:24 pmRNSIssue of Equity
31st Aug 20216:14 pmRNSDirector Shareholdings
25th Aug 20217:00 amRNSInterim Results
13th Jul 20217:00 amRNSNew Release Drives Business Transformation
23rd Jun 20217:00 amRNSSopheon Earns Authority to Operate for NAVSEA
15th Jun 20219:54 amRNSIssue of Equity
10th Jun 202111:43 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.